Nuvation Bio Inc. Report issue

For profit Phase 2
Founded: New York NY United States (2018)

Organization Overview

First Clinical Trial
2020
NCT04541225
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Nuvation Bio Inc. | Nuvation Bio, Inc.